Renal Donor Comparison of Outcomes: Hand Assist Versus Laparoscopic Nephrectomy

Living Renal Donor Clinical Trial

Official title:

Renal Donor Comparison of Outcomes: Hand Assist Versus Laparoscopic Nephrectomy

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT00460889
• Other study ID #: AAAB9478
• Status: Withdrawn
• Phase: N/A
• First received: April 13, 2007
• Last updated: April 2, 2015
• Start date: October 2006
• Est. completion date: August 2008

Study information

• Verified date: April 2015
• Source: Columbia University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

This study is designed to look at outcomes of patients who have undergone hand assisted laparoscopic donor nephrectomy versus totally laparoscopic donor nephrectomy.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: August 2008
• Est. primary completion date: August 2008
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• any person undergoing minimally invasive donor nephrectomy surgery at NewYork Hospital/Columbia.

Exclusion Criteria:

• any person undergoing open donor nephrectomy surgery at NewYork Hospital/Columbia.

Study Design

Time Perspective: Retrospective

Related Conditions & MeSH terms

• Living Renal Donor

Intervention

Procedure:
• donor nephrectomy
The objective of this protocol is to look at the outcomes of laparoscopic donor nephrectomy performed by using hand assisted (HA)or entirely laparoscopic (LDN) surgical techniques. To define the advantages of each technique, we will use records of patients who underwent laparoscopic live kidney donation with HALDN.

Locations

Country	Name	City	State
United States	Columbia University College of Physicians and Surgeons	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
Columbia University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Prevalence of postoperative comfort and hospital stay satisfaction with HALDN		1 week	No
Primary	Prevalence of postoperative comfort and hospital stay satisfaction with LDN		1 week	No